Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)

Conditions:   Opioid-Related Disorders;   Substance-Related Disorders;   Narcotic-Related Disorders Interventions:   Drug: Injectable extended-release buprenorphine;   Drug: Sublingual buprenorphine-naloxone Sponsors:   Yih-Ing Hser;   National Institute on Drug Abuse (NIDA);   National Institutes of Health (NIH);   The Emmes Company, LLC;   University of California, Los Angeles;   RAND;   Cornell University;   Oregon Health and Science University;   University of Illinois at C hicago;   University of Washington;   West Virginia University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials